These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

929 related items for PubMed ID: 12970285

  • 1. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

  • 2. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
    Zelinski-Wooten MB, Hutchison JS, Chandrasekher YA, Wolf DP, Stouffer RL.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
    [Abstract] [Full Text] [Related]

  • 3. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.
    Gonen Y, Balakier H, Powell W, Casper RF.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):918-22. PubMed ID: 2119392
    [Abstract] [Full Text] [Related]

  • 4.
    Holesh JE, Bass AN, Lord M.
    ; 2024 01. PubMed ID: 28723025
    [Abstract] [Full Text] [Related]

  • 5. Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function.
    Zelinski-Wooten MB, Lanzendorf SE, Wolf DP, Chandrasekher YA, Stouffer RL.
    J Clin Endocrinol Metab; 1991 Sep; 73(3):577-83. PubMed ID: 1908481
    [Abstract] [Full Text] [Related]

  • 6. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW, Crowley WF.
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization.
    Segal S, Casper RF.
    Fertil Steril; 1992 Jun; 57(6):1254-8. PubMed ID: 1601147
    [Abstract] [Full Text] [Related]

  • 8. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization.
    San Roman GA, Surrey ES, Judd HL, Kerin JF.
    Fertil Steril; 1992 Oct; 58(4):744-9. PubMed ID: 1426320
    [Abstract] [Full Text] [Related]

  • 9. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist.
    Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM.
    Fertil Steril; 1991 Aug; 56(2):213-20. PubMed ID: 1906406
    [Abstract] [Full Text] [Related]

  • 10. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 11. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S, Charbonnel B, Massai MR, Marraoui J, Spitz I, Bouchard P.
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [Abstract] [Full Text] [Related]

  • 12.
    ; 2012 Sep. PubMed ID: 31644163
    [Abstract] [Full Text] [Related]

  • 13. Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol.
    Cunha Filho JS, Terres LF, Holanda F, Freitas F, Glitz C, Genro VK, Arbo E.
    J Assist Reprod Genet; 2007 Aug; 24(8):326-30. PubMed ID: 17636446
    [Abstract] [Full Text] [Related]

  • 14. Suppression of pulsatile luteinizing hormone secretion by gonadotrophin-releasing hormone antagonist does not affect episodic progesterone secretion or corpus luteum function in ewes.
    McNeilly AS, Crow WJ, Fraser HM.
    J Reprod Fertil; 1992 Nov; 96(2):865-74. PubMed ID: 1339865
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE, Schoenfeld DA, Martin KA, Crowley WF.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [Abstract] [Full Text] [Related]

  • 16. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 17. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.
    Chen Y, Zhang Y, Hu M, Liu X, Qi H.
    Gynecol Endocrinol; 2014 Jun; 30(6):431-7. PubMed ID: 24731070
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R, Dyrenfurth I, Ferin M, Bogumil J, Vande Wiele RL.
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [Abstract] [Full Text] [Related]

  • 19. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
    Brzyski RG, Jones GS, Jones HW, Oehninger S, Muasher SJ.
    Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
    [Abstract] [Full Text] [Related]

  • 20. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM, Roseff SJ, Chiu TC, Bangah ML, Vale W, Rivier J, Burger HG, Yen SS.
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.